Breathing life into new markets.
Many businesses in the life sciences sector are considering mergers or acquisitions
and collaboration arrangements to expand their portfolios of existing products. Others are looking to expand overseas into new markets. Most of these transactions are complex, multi-faceted, and create significant uncertainty regarding financial reporting. Businesses dealing with these issues require advisors with experience and insight into these arrangements and the many challenges that come with them.
From understanding the complexities of research and development tax credits
and FDA regulations, to licensing agreements and due diligence
, BDO’s Technology and Life Sciences Practice provides guidance to pharmaceutical, biotech, and medical device manufacturers at every stage of development.
Importantly, BDO advises clients on how best to access capital, which is crucial to fueling innovation, research, and development efforts. From a tax perspective, BDO identifies significant opportunities to drive value, and assists businesses in structuring their operations in the most tax-efficient manner possible.